Patent 12112357B2

Extensions

Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.

Active provider: Google · gemini-2.5-flash

Extensions

Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.

✓ Generated

To provide a comprehensive analysis of US patent 12112357B2 regarding patent term adjustments, extensions, continuations, divisional applications, related family members, and its projected expiration date, I will rely on the provided patent text and the general rules governing patent terms from the USPTO. The USPTO does not calculate expiration dates for patents but provides resources to help estimate them.

Patent Term Adjustments (PTA)

Patent Term Adjustment (PTA) adds time to a patent's term to compensate for delays caused by the USPTO during prosecution of a utility or plant patent application. PTA is determined after a patent has been granted and is based on specific types of delays, such as the USPTO failing to issue a first Office Action within 14 months, respond to an applicant's reply within four months, or issue a patent within four months of the issue fee payment. Applicant delays can reduce any accrued PTA.

The provided patent text for US12112357B2 does not explicitly state the amount of any Patent Term Adjustment granted. Such information would typically be detailed in the patent document itself or available through USPTO's Patent Center. Without direct access to the official USPTO record for PTA on this specific patent, the exact PTA amount cannot be determined.

Patent Term Extensions (PTE)

Patent Term Extensions (PTE) are typically granted under 35 U.S.C. § 156 for patents on certain human drugs, food or color additives, medical devices, animal drugs, and veterinary biological products to restore time lost during premarket government approval from a regulatory agency like the FDA. PTE can extend the patent term for up to five years, and the total patent life with a PTE cannot exceed 14 years from the date of FDA approval.

Based on the title "Mobile device streaming media application" and the subject matter described in the patent (software-related), US12112357B2 is highly unlikely to be eligible for a Patent Term Extension under 35 U.S.C. § 156, as it does not appear to claim a product subject to regulatory review by agencies such as the FDA. The patent text does not mention any regulatory review or an application for PTE.

Continuation and Divisional Applications

The patent text indicates that US12112357B2 (Application No. US18/423,160) is a continuation of a series of patent applications. Specifically, the "CROSS-REFERENCE TO RELATED APPLICATIONS" section states:

"This application is a continuation of U.S. patent application Ser. No. 18/346,318, filed Jul. 3, 2023, which is a continuation of U.S. patent application Ser. No. 17/705,331, filed Mar. 27, 2022, which is a continuation of U.S. patent application Ser. No. 17/384,911, filed Jul. 26, 2021, which is a continuation of U.S. patent application Ser. No. 16/812,495, filed Mar. 9, 2020, which is a continuation of U.S. patent application Ser. No. 16/790,953, filed Feb. 14, 2020, which is a continuation of U.S. patent application Ser. No. 16/157,269, filed Oct. 11, 2018, which is a continuation of U.S. patent application Ser. No. 15/273,335, filed Sep. 22, 2016, which is a continuation of U.S. patent application Ser. No. 15/041,422, filed Feb. 11, 2016, which is a continuation of U.S. patent application Ser. No. 14/512,353, filed Oct. 10, 2014, which is a continuation of U.S. patent application Ser. No. 13/967,414, filed Aug. 15, 2013, which is a continuation of U.S. patent application Ser. No. 13/027,191, filed Feb. 14, 2011, which claims priority to U.S. Provisional Patent Application No. 61/304,331, filed Feb. 12, 2010."

This clearly establishes a chain of continuation applications, all tracing back to U.S. Provisional Patent Application No. 61/304,331, filed on February 12, 2010. The "Family Applications" section also lists numerous other related applications, many of which appear to be continuations or divisionals within the same family, all claiming priority to the same February 12, 2010 date.

Related Family Members

The "Family Applications" section on the Google Patents page for US12112357B2 lists 19 applications, including US12112357B2 itself. These are:

All of these applications claim the same priority date of February 12, 2010.

Projected Expiration Date

For utility patents filed on or after June 8, 1995, the patent term generally ends 20 years from the date on which the application for the patent was filed in the United States, or 20 years from the filing date of the earliest application to which a benefit is claimed under 35 U.S.C. 120, 121, or 365(c). Since US12112357B2 claims priority to a provisional application filed on February 12, 2010, the 20-year term is calculated from this earliest priority date.

Therefore, the base expiration date (without considering any PTA or terminal disclaimers) would be February 12, 2010 + 20 years = February 12, 2030.

The patent summary states an "Anticipated expiration" date of February 14, 2031. This suggests that there might be a Patent Term Adjustment (PTA) of approximately one year and two days (from February 12, 2030, to February 14, 2031). Such an adjustment would compensate for delays in prosecution at the USPTO.

Therefore, the projected expiration date, as indicated in the patent information, is February 14, 2031.

Generated 5/28/2026, 1:56:17 PM